Skip to content

Khan Najat

Reporting owner on Forms 3, 4 and 5, CIK 2020969.

Khan Najat reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-18.

Issuers

IssuerRoles in the latest filingFilingsLast filed
RXRX · RECURSION PHARMACEUTICALS, INC.CIK 1601830director, officer (CEO and President)12026-11-18

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
RXRX · RECURSION PHARMACEUTICALS, …Class A Common Stock2026-11-16F withheld for tax-85,815$3.1851,987,075Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001601830-26-000155 RECURSION PHARMACEUTICALS, INC.2026-11-18